SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-046096
Filing Date
2024-04-11
Accepted
2024-04-11 08:03:10
Documents
15
Period of Report
2024-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2411574d1_8k.htm   iXBRL 8-K 31202
2 EXHIBIT 99.1 tm2411574d1_ex99-1.htm EX-99.1 10733
6 GRAPHIC tm2411574d1_ex99-1img001.jpg GRAPHIC 4130
  Complete submission text file 0001104659-24-046096.txt   228271

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20240410.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20240410_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20240410_pre.xml EX-101.PRE 22391
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2411574d1_8k_htm.xml XML 3700
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 24837166
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)